Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Tanke Biosciences Corp | f8k122012_tanke.htm |
Exhibit 16.1
December 24, 2012
Office of the Chief Accountant
Securities and Exchange Commission
460 Fifth Street N. W.
Washington, DC 20549
Dear Sirs:
We have received a copy of, and are in agreement with, the statements being made by Tanke Biosciences Corporation (the “Registrant”) in Item 4.01 of its Form 8-K dated December 20, 2012, captioned “Changes in Registrant’s Certifying Accountant.”
We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
Sincerely,
/s/ EFP Rotenberg, LLP
EFP Rotenberg, LLP
/gt